O
MRTX

OppenheimerFunds’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

OppenheimerFunds’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$60.1M Buy
819,956
+3,146
+0.4% +$214K 0.07% 268
2018
Q4 		$34.6M Buy
816,810
+291,544
+56% +$11.6M 0.05% 361
2018
Q3 		$24.7M Sell
525,266
-3,579
-0.7% -$199K 0.03% 530
2018
Q2 		$26.1M Buy
+528,845
New +$20M 0.03% 515

Other funds holding MRTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
AH
Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

OppenheimerFunds's MRTX Position: Q1 2019 in Review

OppenheimerFunds increased its Mirati Therapeutics, Inc. Common Stock (MRTX) stake by 0.39% in Q1 2019, buying an estimated $214K and bringing the position to 819,956 shares worth $60.1M. The position accounts for 0.07% of the portfolio, ranked #268.

OppenheimerFunds first reported a position in MRTX in Q2 2018 and has held it in 4 quarters since. 159 funds tracked by Wall St. Rank hold MRTX as of Q1 2019.

  • OppenheimerFunds held 819,956 shares of Mirati Therapeutics, Inc. Common Stock worth $60.1M as of Q1 2019.
  • OppenheimerFunds bought 3,146 Mirati Therapeutics, Inc. Common Stock shares in Q1 2019, an estimated $214K.
  • Mirati Therapeutics, Inc. Common Stock made up 0.07% of OppenheimerFunds's portfolio in Q1 2019, its #268 holding.
  • OppenheimerFunds first reported a position in Mirati Therapeutics, Inc. Common Stock in Q2 2018 and has held it in 4 quarters since.
  • 159 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q1 2019.

Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.